Approved indications: Oral isotretinoin is FDA‑approved for the treatment of severe recalcitrant nodular acne in nonpregnant patients 12 years of age and older whose acne has not responded to adequate courses of other therapies, including systemic antibiotics.

Common off‑label uses (evidence generally from small studies or case series):

• Treatment‑resistant moderate acne or acne that relapses quickly after other systemic treatments.
• Certain difficult inflammatory skin conditions such as severe or refractory rosacea, some follicular disorders (e.g., folliculitis decalvans), and selected cases of hidradenitis suppurativa, when standard options have failed.

Efficacy expectations:

• Many patients notice meaningful improvement in acne within 4–8 weeks, with maximal clearing usually by the end of a 15–20 week course.
• A single full cumulative course leads to long‑term or permanent remission in a large proportion of patients, though some will need a second course or intermittent additional acne treatment.
• Compared with oral antibiotics, hormonal therapies, and topical regimens, isotretinoin is generally the most effective option for severe nodular acne, offering deeper and more durable clearance but with stricter safety monitoring and pregnancy‑prevention requirements.

Typical dosing and how to take it:

• Most patients 12 years and older start at about 0.5 mg/kg/day, divided into two doses, and may increase to 1 mg/kg/day (or occasionally up to 2 mg/kg/day in very severe trunk‑predominant acne) based on response and tolerance.
• The usual treatment course lasts about 15–20 weeks, aiming for a total cumulative dose near 120–150 mg/kg to reduce relapse risk.
• Traditional formulations should be taken with a meal that contains some fat to improve absorption; certain newer “lidose” or micronized brands can be taken with or without food—follow the specific product instructions.
• Swallow capsules whole with a full glass of water; do not crush, chew, or open them, and avoid lying down immediately afterward.

Special dosing instructions:

• Your prescriber may start at a lower dose if you have significant side effects, liver or kidney concerns, very high triglycerides, or are an older or very sensitive patient.
• Doctors may pause treatment, reduce the dose, or extend the total course length to manage troublesome side effects while still reaching an adequate cumulative dose.

Missed dose guidance:

• If you miss a dose, take it as soon as you remember the same day, unless it is almost time for your next dose; if it is close to the next scheduled dose, skip the missed dose and resume your regular schedule.
• Do not double up doses to make up for a missed capsule.

Overdose:

• If you or someone else takes more than the prescribed amount, call your prescriber, poison control (1‑800‑222‑1222 in the U.S.), or seek emergency care right away, especially if symptoms like severe headache, vomiting, dizziness, or stomach pain occur.

Common side effects (very frequent, usually dose‑related):

• Dry or chapped lips, dry skin, nose dryness or nosebleeds, and dry eyes, often starting within the first weeks and usually manageable with moisturizers, lip balm, saline spray, and artificial tears.
• Temporary flare of acne early in treatment, mild joint or muscle aches, fatigue, and increased sensitivity to sun.
• Laboratory changes such as elevated triglycerides or cholesterol and mild liver enzyme elevations, which are usually reversible after dose adjustment or stopping the drug.

Serious or rare adverse effects needing immediate medical attention:

• Pregnancy exposure (or suspected pregnancy) due to a very high risk of severe birth defects, miscarriage, and premature birth.
• Severe headache with nausea, vomiting, vision changes, or dizziness (possible increased pressure in the skull), or sudden vision or hearing problems.
• Severe abdominal pain, persistent nausea/vomiting, or jaundice (yellowing of skin or eyes), which may signal pancreatitis or liver injury.
• Severe mood or behavior changes such as depression, new or worsening anxiety, irritability, or suicidal thoughts.
• Bloody diarrhea or severe stomach cramps that could indicate inflammatory bowel disease, and any signs of a serious allergic reaction (trouble breathing, facial or throat swelling, widespread rash).

Warnings and precautions:

• Pregnancy: Absolute contraindication; in the U.S., all patients must be enrolled in the iPLEDGE program, and patients who can become pregnant must have regular pregnancy tests and use two effective forms of birth control before, during, and for at least one month after treatment.
• Breastfeeding: Not recommended because isotretinoin may pass into breast milk and harm the infant.
• Age limits: Safety and effectiveness are established in patients 12 years and older; it is generally avoided in younger children due to limited data and concerns about bone growth.
• Kidney and liver disease: Use with caution or avoid in significant hepatic impairment or severe renal disease, with possible dose reductions and closer lab monitoring.
• Other conditions: Use carefully in patients with high baseline lipids, diabetes, obesity, a history of depression or other psychiatric illness, bone disorders, or inflammatory bowel disease, balancing risks and benefits.

Safety compared with other acne drugs: Isotretinoin offers superior long‑term clearing for severe acne but carries unique, serious risks—especially teratogenicity and lab abnormalities—so it is reserved for carefully selected patients and requires more intensive monitoring than standard topical treatments or oral antibiotics.

Side‑effect reporting and safety updates: Patients should promptly report side effects to their prescriber or pharmacist and can report serious events directly to FDA MedWatch; up‑to‑date safety information and any new warnings are available on the FDA and iPLEDGE program websites.

Key drug and supplement interactions:

• Vitamin A and other retinoids: Avoid vitamin A supplements and other retinoid medicines (such as acitretin or topical tretinoin on large areas) because of the risk of additive toxicity similar to hypervitaminosis A.
• Tetracycline antibiotics: Combining isotretinoin with tetracyclines (e.g., minocycline, doxycycline) increases the risk of raised intracranial pressure and is generally avoided.
• Other interacting medicines: Use caution with drugs that affect bone metabolism (such as long‑term systemic corticosteroids or some anticonvulsants like phenytoin) and with strong hepatotoxic or lipid‑raising drugs, since side effects on liver and lipids may be amplified.
• Hormonal contraception and herbal products: Effective contraception is required; avoid herbal products like St. John’s wort that can reduce hormonal contraceptive effectiveness and increase pregnancy risk.
• Alcohol: Alcohol can worsen triglyceride elevations and liver stress while on isotretinoin, so intake should be limited or avoided.

Food, lifestyle, and procedure considerations:

• Avoid blood donation during treatment and for at least one month after the last dose to prevent exposing pregnant recipients to the drug.
• Do not undergo elective waxing, dermabrasion, or aggressive laser resurfacing during therapy and for a period afterward, as skin may be fragile and scar more easily; discuss timing with your dermatologist.
• Use broad‑spectrum sunscreen and protective clothing, since skin is more sensitive to sunlight and sunburn.

Conditions and co‑medications that require extra caution:

• Pre‑existing high triglycerides, low HDL, obesity, diabetes, metabolic syndrome, liver disease, or strong family history of early heart disease.
• Personal history of depression, anxiety, other significant psychiatric disorders, or suicidal behavior.
• History of inflammatory bowel disease, severe headaches or pseudotumor cerebri, or significant bone or growth disorders.

Monitoring needs:

• Baseline and periodic blood tests are usually done, including fasting lipids and liver function tests; some clinicians also monitor a complete blood count.
• Patients who can become pregnant must have regular pregnancy tests as required by the iPLEDGE program.
• Ongoing assessment of mood, vision, headaches, musculoskeletal symptoms, and gastrointestinal complaints is important throughout treatment.

Q: How long will I need to take isotretinoin, and when will I see results?
A: Most courses last about 4–5 months, many people start to see improvement within 4–8 weeks, and maximal clearing usually appears by the end of the course.

Q: Will my acne come back after I finish isotretinoin?
A: Many patients have long‑lasting or permanent remission, but some—especially those with very severe or early‑onset acne—may have partial relapse and occasionally need a second course or other maintenance treatments.

Q: Can I drink alcohol while I am on isotretinoin?
A: Your doctor may ask you to avoid or strictly limit alcohol, because both alcohol and isotretinoin can raise triglycerides and stress the liver.

Q: Why is pregnancy such a big concern with isotretinoin?
A: Isotretinoin can cause very serious birth defects and pregnancy loss, so people who can become pregnant must use strict birth control, have regular pregnancy tests, and follow all iPLEDGE requirements.

Q: Can I donate blood while taking isotretinoin?
A: No; you should not donate blood during treatment or for at least one month after your last dose, to avoid the risk that your blood could be given to someone who is pregnant.

Q: Do I need special eye or skin care during isotretinoin treatment?
A: Yes, most people need frequent lip balm, gentle moisturizers, artificial tears if eyes are dry, and daily sunscreen, and should avoid harsh scrubs, peels, and waxing until the skin recovers.

Storage: Keep isotretinoin capsules at room temperature (generally 68–77°F / 20–25°C), away from excess heat, moisture, and direct light, and store them in the original child‑resistant packaging out of reach of children and pets.

Handling and safety: Because isotretinoin can cause severe birth defects, do not share it with anyone, do not remove capsules from their labeled container in advance, and people who are or may become pregnant should avoid handling leaking or broken capsules.

Disposal: If you have leftover capsules, do not throw them in household trash or flush them down the toilet unless specifically instructed; instead, return them to a pharmacy take‑back program or follow your pharmacist’s or local waste authority’s instructions for hazardous medicine disposal.